(19)

(11)

EP 4 739 712 A1

(12)

(43) Date of publication: 13.05.2026 Bulletin 2026/20 (21) Application number: 24835390.6 (22) Date of filing: 04.07.2024

(51) International Patent Classification (IPC):  C07K 16/28(2006.01) A61K 47/68(2017.01) C07K 16/40(2006.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; C07K 16/2803; C07K 2317/24; C07K 2317/92; C07K 2317/565 (86) International application number: PCT/CN2024/103509 (87) International publication number: WO 2025/007910 (09.01.2025 Gazette 2025/02)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 04.07.2023 WO PCT/CN2023/105698 (71) Applicant: TJ Biopharma (Shanghai) Co., Ltd. Shanghai 201210 (CN)	(72) Inventors: LIU, Chanjuan Shanghai 201210 (CN) XING, Xiaojun Shanghai 201210 (CN) (74) Representative: Gleiss Große Schrell und Partner mbB  Leitzstraße 45 70469 Stuttgart 70469 Stuttgart (DE)